PRIMARY BILIARY CHOLANGITIS (PBC)
Clinical trials for PRIMARY BILIARY CHOLANGITIS (PBC) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS (PBC) trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS (PBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver disease patients in clinical trial
Disease control OngoingThis study is testing an experimental drug called CS0159 for people with Primary Biliary Cholangitis (PBC), a chronic liver disease. It will involve 75 participants and last about one year, with the first 12 weeks comparing the drug to a placebo. The main goals are to see if CS01…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for Tough-to-Treat liver condition
Disease control ENROLLING_BY_INVITATIONThis study is testing if adding the steroid prednisone to the standard liver disease drug UDCA works better for people with a specific form of primary biliary cholangitis (PBC). It focuses on patients whose liver biopsies show moderate-to-severe inflammation, a group that often d…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: PHASE2, PHASE3 • Sponsor: Han Ying • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC